Milestone Pharmaceuticals Inc

MIST

Company Profile

  • Business description

    Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

  • Contact

    1111 Dr. Frederik-Philips Boulevard
    Suite 420
    MontrealQCH4M 2X6
    CAN

    T: +1 514 336-0444

    https://www.milestonepharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    33

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,826.7048.800.56%
CAC 407,900.0321.570.27%
DAX 4024,465.9683.60-0.34%
Dow JONES (US)44,714.68256.380.58%
FTSE 1008,975.60108.581.22%
HKSE24,028.37136.050.57%
NASDAQ20,579.8031.53-0.15%
Nikkei 22539,646.36174.92-0.44%
NZX 50 Index12,760.208.41-0.07%
S&P 5006,274.4711.210.18%
S&P/ASX 2008,589.2050.600.59%
SSE Composite Index3,509.6816.630.48%

Market Movers